Previous Close | 4.2000 |
Open | 4.0000 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 3.8100 - 4.0000 |
52 Week Range | 2.5500 - 5.9700 |
Volume | |
Avg. Volume | 5,519 |
Market Cap | 6.002M |
Beta (5Y Monthly) | 2.58 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Xenetic Biosciences (XBIO) delivered earnings and revenue surprises of 1.27% and 21.39%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Xenetic Biosciences ( NASDAQ:XBIO ) Full Year 2023 Results Key Financial Results Revenue: US$2.54m (up 49% from FY...
Key Insights Xenetic Biosciences will host its Annual General Meeting on 6th of December Total pay for CEO Jeff...